Stay updated on Inhaled Treprostinil in COPD-Associated PH Clinical Trial
Sign up to get notified when there's something new on the Inhaled Treprostinil in COPD-Associated PH Clinical Trial page.

Latest updates to the Inhaled Treprostinil in COPD-Associated PH Clinical Trial page
- Check5 days agoChange DetectedThe footer revision identifier changed from v3.7.2 to v3.8.0, while the page continues to show a 403 Forbidden error.SummaryDifference0.2%

- Check12 days agoNo Change Detected
- Check19 days agoChange DetectedA general NIH announcement about terminology changes appears above the ClinicalTrials.gov 403 error page. The displayed site revision advances from v3.7.1 to v3.7.2.SummaryDifference1%

- Check33 days agoChange DetectedThe site revision identifier in the footer changes from v3.7.0 to v3.7.1 on the 403 Forbidden page.SummaryDifference0.2%

- Check47 days agoChange DetectedThe page now displays a 403 Forbidden error, blocking access to the study record and related sections on the ClinicalTrials.gov page. This change affects how the page is accessed rather than the study information itself.SummaryDifference18%

- Check54 days agoChange DetectedThe page's revision label updated to v3.7.0, replacing the previous v3.6.6 in the version metadata.SummaryDifference0.0%

- Check61 days agoChange DetectedQiryat Krinitzi, Israel, 52621, was removed from the study's Israel locations. Tel Litwinsky, Israel, 52621, was added as a new site.SummaryDifference0.0%

Stay in the know with updates to Inhaled Treprostinil in COPD-Associated PH Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Inhaled Treprostinil in COPD-Associated PH Clinical Trial page.